Eva Slabáková

1.0k total citations
19 papers, 801 citations indexed

About

Eva Slabáková is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Eva Slabáková has authored 19 papers receiving a total of 801 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Eva Slabáková's work include Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Eva Slabáková is often cited by papers focused on Cancer Cells and Metastasis (6 papers), Prostate Cancer Treatment and Research (5 papers) and Cancer-related Molecular Pathways (4 papers). Eva Slabáková collaborates with scholars based in Czechia, Austria and United States. Eva Slabáková's co-authors include Karel Souček, Ján Remšík, Zoran Čulig, Alois Kozubı́k, Zuzana Pernicová, Jan Bouchal, Michela Muscettola, Nila Volpi, Claudia Torricelli and Emanuela Maioli and has published in prestigious journals such as Scientific Reports, British Journal of Cancer and Human Reproduction.

In The Last Decade

Eva Slabáková

19 papers receiving 799 citations

Peers

Eva Slabáková
Hong Yin China
Weiyan Peng China
Xiaofang Lu China
Jung Lim Kim South Korea
Somy Yoon South Korea
Fengxiang Wei China
Pattatheyil Arun India
Huanran Tan China
Hong Yin China
Eva Slabáková
Citations per year, relative to Eva Slabáková Eva Slabáková (= 1×) peers Hong Yin

Countries citing papers authored by Eva Slabáková

Since Specialization
Citations

This map shows the geographic impact of Eva Slabáková's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eva Slabáková with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eva Slabáková more than expected).

Fields of papers citing papers by Eva Slabáková

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eva Slabáková. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eva Slabáková. The network helps show where Eva Slabáková may publish in the future.

Co-authorship network of co-authors of Eva Slabáková

This figure shows the co-authorship network connecting the top 25 collaborators of Eva Slabáková. A scholar is included among the top collaborators of Eva Slabáková based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eva Slabáková. Eva Slabáková is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Slabáková, Eva, et al.. (2021). Regulation of Neuroendocrine-like Differentiation in Prostate Cancer by Non-Coding RNAs. Non-Coding RNA. 7(4). 75–75. 6 indexed citations
2.
Remšík, Ján, Radek Fedr, Jan Bouchal, et al.. (2020). Slug-expressing mouse prostate epithelial cells have increased stem cell potential. Stem Cell Research. 46. 101844–101844. 18 indexed citations
3.
Slabáková, Eva, Lucia Binó, Ján Remšík, et al.. (2019). Generation of human iPSCs from fetal prostate fibroblasts HPrF. Stem Cell Research. 35. 101405–101405. 3 indexed citations
4.
Fedr, Radek, Ján Remšík, Eva Slabáková, et al.. (2019). High Skp2 expression is associated with a mesenchymal phenotype and increased tumorigenic potential of prostate cancer cells. Scientific Reports. 9(1). 5695–5695. 25 indexed citations
5.
Remšík, Ján, Radek Fedr, Jiří Navrátil, et al.. (2018). Plasticity and intratumoural heterogeneity of cell surface antigen expression in breast cancer. British Journal of Cancer. 118(6). 813–819. 23 indexed citations
6.
Souček, Karel, Ján Remšík, Zuzana Holubcová, et al.. (2018). Presence of growth/differentiation factor-15 cytokine in human follicular fluid, granulosa cells, and oocytes. Journal of Assisted Reproduction and Genetics. 35(8). 1407–1417. 11 indexed citations
7.
Slabáková, Eva, Lucia Binó, Ján Remšík, et al.. (2018). Generation of human iPSCs from human prostate cancer-associated fibroblasts IBPi002-A. Stem Cell Research. 33. 255–259. 3 indexed citations
8.
Remšík, Ján, Lucia Binó, Gvantsa Kharaishvili, et al.. (2018). Trop-2 plasticity is controlled by epithelial-to-mesenchymal transition. Carcinogenesis. 39(11). 1411–1418. 21 indexed citations
9.
Slabáková, Eva, Zoran Čulig, Ján Remšík, & Karel Souček. (2017). Alternative mechanisms of miR-34a regulation in cancer. Cell Death and Disease. 8(10). e3100–e3100. 210 indexed citations
10.
Šimková, Dana, Gvantsa Kharaishvili, Eva Slabáková, Philip I. Murray, & Jan Bouchal. (2016). Glycoprotein asporin as a novel player in tumour microenvironment and cancer progression. Biomedical Papers. 160(4). 467–473. 14 indexed citations
11.
Slabáková, Eva, Gvantsa Kharaishvili, Zuzana Pernicová, et al.. (2015). Opposite regulation of MDM2 and MDMX expression in acquisition of mesenchymal phenotype in benign and cancer cells. Oncotarget. 6(34). 36156–36171. 18 indexed citations
12.
Hackl, Hubert, Eva Slabáková, Ilse Schwarzinger, et al.. (2014). The oncogeneEVI1enhances transcriptional and biological responses of human myeloid cells toall-transretinoic acid. Cell Cycle. 13(18). 2931–2943. 19 indexed citations
13.
Pernicová, Zuzana, Eva Slabáková, Radek Fedr, et al.. (2014). The role of high cell density in the promotion of neuroendocrine transdifferentiation of prostate cancer cells. Molecular Cancer. 13(1). 113–113. 26 indexed citations
14.
Fedr, Radek, Zuzana Pernicová, Eva Slabáková, et al.. (2013). Automatic cell cloning assay for determining the clonogenic capacity of cancer and cancer stem‐like cells. Cytometry Part A. 83A(5). 472–482. 27 indexed citations
15.
Staršíchová, Andrea, Eva Hrubá, Eva Slabáková, et al.. (2012). TGF-β1 signaling plays a dominant role in the crosstalk between TGF-β1 and the aryl hydrocarbon receptor ligand in prostate epithelial cells. Cellular Signalling. 24(8). 1665–1676. 16 indexed citations
16.
Torricelli, Claudia, Giuseppe Valacchi, Karel Souček, et al.. (2012). Alternative Pathways of Cancer Cell Death by Rottlerin: Apoptosis versus Autophagy. Evidence-based Complementary and Alternative Medicine. 2012. 1–11. 180 indexed citations
17.
Slabáková, Eva, et al.. (2011). TGF‐β1‐induced EMT of non‐transformed prostate hyperplasia cells is characterized by early induction of SNAI2/Slug. The Prostate. 71(12). 1332–1343. 88 indexed citations
18.
Pernicová, Zuzana, Eva Slabáková, Gvantsa Kharaishvili, et al.. (2011). Androgen Depletion Induces Senescence in Prostate Cancer Cells through Down-regulation of Skp2. Neoplasia. 13(6). 526–IN13. 67 indexed citations
19.
Souček, Karel, et al.. (2010). Growth/differentiation factor-15 is an abundant cytokine in human seminal plasma. Human Reproduction. 25(12). 2962–2971. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hong Yin Breakdown of academic impact, for papers by Weiyan Peng Breakdown of academic impact, for papers by Xiaofang Lu Breakdown of academic impact, for papers by Jung Lim Kim Breakdown of academic impact, for papers by Somy Yoon Breakdown of academic impact, for papers by Fengxiang Wei Breakdown of academic impact, for papers by Pattatheyil Arun Breakdown of academic impact, for papers by Huanran Tan
Rankless by CCL
2026